Ethinyl estradiol and levonorgestrel extended-cycle is a combination drug that contains female hormones that prevent ovulation (the release of an egg from an ovary). This medication also causes changes in your cervical mucus and uterine lining, making it harder for sperm to reach the uterus and harder for a fertilized egg to attach to the uterus. Ethinyl estradiol and levonorgestrel extended-cycle is used as contraception to prevent pregnancy. Ethinyl estradiol and levonorgestrel extended-cycle may also be used for purposes not listed in this medication guide.
Loseasonique was first developed by Barr Pharmaceuticals in conjunction with Eastern Virginia Medical School and approved by the United States Food and Drug Administration on September 5, 2003. Recently, the Food and Drug Administration approved several pharmaceutical companies to manufacture loseasonique. This drug contains 2 female hormones namely ethinyl estradiol and levonorgestrel which prevent ovulation.